Jani, Bb Girl .
HRN: 25-57-40 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/28/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/28/2024
08/03/2024
IVT
48mg
Q24
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes